However, the immunosuppressive microenvironment (such as angiogenesis and high expression of PD-L1 in the tumor microenvironment) will still significantly inhibit the antitumor activity of tumor-specific T cells induced by neoantigen vaccine. The gene discussed is CD274; the disease is neoplasm.